California State Teachers Retirement System Tg Therapeutics, Inc. Transaction History

California State Teachers Retirement System

  • $83.3 Billion
  • Q4 2024

A detailed history of California State Teachers Retirement System transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 137,002 shares of TGTX stock, worth $4.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
137,002
Previous 138,351 0.98%
Holding current value
$4.25 Million
Previous $3.24 Million 27.41%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$21.31 - $35.09 $28,747 - $47,336
-1,349 Reduced 0.98%
137,002 $4.12 Million
Q3 2024

Nov 14, 2024
SELL
$17.21 - $25.28 $75,310 - $110,625
-4,376 Reduced 3.07%
138,351 $3.24 Million
Q2 2024

Aug 14, 2024
SELL
$13.32 - $19.19 $7,912 - $11,398
-594 Reduced 0.41%
142,727 $2.54 Million
Q1 2024

May 15, 2024
SELL
$13.02 - $21.3 $94,486 - $154,574
-7,257 Reduced 4.82%
143,321 $2.18 Million
Q4 2023

Feb 13, 2024
SELL
$6.68 - $18.81 $34,188 - $96,269
-5,118 Reduced 3.29%
150,578 $2.57 Million
Q3 2023

Nov 14, 2023
SELL
$8.36 - $26.5 $102,828 - $325,950
-12,300 Reduced 7.32%
155,696 $1.3 Million
Q2 2023

Aug 21, 2023
SELL
$15.48 - $35.0 $44,288 - $100,135
-2,861 Reduced 1.67%
167,996 $4.17 Million
Q1 2023

May 09, 2023
SELL
$10.23 - $19.34 $23,651 - $44,714
-2,312 Reduced 1.34%
170,857 $2.57 Million
Q4 2022

Feb 14, 2023
BUY
$5.01 - $11.83 $12,525 - $29,575
2,500 Added 1.46%
173,169 $2.05 Million
Q3 2022

Nov 18, 2022
SELL
$4.57 - $8.4 $8,678 - $15,951
-1,899 Reduced 1.1%
170,669 $1.01 Million
Q2 2022

Aug 15, 2022
BUY
$3.74 - $10.66 $49,248 - $140,370
13,168 Added 8.26%
172,568 $733,000
Q1 2022

May 16, 2022
SELL
$7.81 - $20.45 $108,902 - $285,154
-13,944 Reduced 8.04%
159,400 $1.52 Million
Q4 2021

Feb 15, 2022
BUY
$15.2 - $35.51 $86,062 - $201,057
5,662 Added 3.38%
173,344 $3.29 Million
Q3 2021

Nov 15, 2021
SELL
$21.78 - $40.45 $195,388 - $362,876
-8,971 Reduced 5.08%
167,682 $5.58 Million
Q2 2021

Aug 16, 2021
SELL
$32.5 - $48.96 $222,592 - $335,327
-6,849 Reduced 3.73%
176,653 $6.85 Million
Q1 2021

May 18, 2021
BUY
$41.61 - $54.3 $372,575 - $486,202
8,954 Added 5.13%
183,502 $8.85 Million
Q4 2020

Feb 16, 2021
BUY
$25.27 - $54.9 $163,673 - $355,587
6,477 Added 3.85%
174,548 $9.08 Million
Q3 2020

Nov 17, 2020
BUY
$18.49 - $27.24 $409,886 - $603,856
22,168 Added 15.19%
168,071 $4.5 Million
Q2 2020

Aug 17, 2020
BUY
$8.9 - $21.84 $140,157 - $343,936
15,748 Added 12.1%
145,903 $2.84 Million
Q1 2020

May 13, 2020
SELL
$7.14 - $15.99 $10,481 - $23,473
-1,468 Reduced 1.12%
130,155 $1.28 Million
Q4 2019

Feb 14, 2020
BUY
$5.1 - $11.2 $19,492 - $42,806
3,822 Added 2.99%
131,623 $1.46 Million
Q3 2019

Nov 15, 2019
BUY
$5.38 - $8.99 $36,320 - $60,691
6,751 Added 5.58%
127,801 $718,000
Q2 2019

Aug 14, 2019
BUY
$6.27 - $8.65 $156,028 - $215,255
24,885 Added 25.88%
121,050 $1.05 Million
Q1 2019

May 09, 2019
SELL
$4.02 - $8.04 $8,872 - $17,744
-2,207 Reduced 2.24%
96,165 $773,000
Q4 2018

Feb 13, 2019
BUY
$3.44 - $5.76 $7,860 - $13,161
2,285 Added 2.38%
98,372 $403,000
Q3 2018

Nov 14, 2018
BUY
$5.15 - $14.0 $28,567 - $77,658
5,547 Added 6.13%
96,087 $538,000
Q2 2018

Aug 14, 2018
BUY
$12.5 - $15.0 $154,250 - $185,100
12,340 Added 15.78%
90,540 $1.19 Million
Q1 2018

May 15, 2018
SELL
$8.7 - $16.8 $23,846 - $46,048
-2,741 Reduced 3.39%
78,200 $1.11 Million
Q4 2017

Feb 14, 2018
BUY
$7.35 - $12.3 $24,188 - $40,479
3,291 Added 4.24%
80,941 $664,000
Q3 2017

Nov 13, 2017
BUY
$10.0 - $12.7 $776,500 - $986,155
77,650
77,650 $920,000

Others Institutions Holding TGTX

# of Institutions
370
Shares Held
85.5M
Call Options Held
3.78M
Put Options Held
3M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.5B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email